<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="letter">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="iso-abbrev">Emerging Infect. Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26488454</article-id>
      <article-id pub-id-type="pmc">4622260</article-id>
      <article-id pub-id-type="publisher-id">15-0850</article-id>
      <article-id pub-id-type="doi">10.3201/eid2111.150850</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Letters to the Editor</subject>
        </subj-group>
        <subj-group subj-group-type="article-type">
          <subject>Letter</subject>
        </subj-group>
        <subj-group subj-group-type="TOC-title">
          <subject>G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>G2P[4]-RotaTeq Reassortant Rotavirus in Vaccinated Child, United States</article-title>
        <alt-title alt-title-type="running-head">G2P[4]-RotaTeq Reassortant Rotavirus</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Roy</surname>
            <given-names>Sunando</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rungsrisuriyachai</surname>
            <given-names>Kunchala</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Esona</surname>
            <given-names>Mathew D.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Boom</surname>
            <given-names>Julie A.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sahni</surname>
            <given-names>Leila C.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Rench</surname>
            <given-names>Marcia A.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Baker</surname>
            <given-names>Carol J.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wikswo</surname>
            <given-names>Mary E.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Payne</surname>
            <given-names>Daniel C.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Parashar</surname>
            <given-names>Umesh D.</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Bowen</surname>
            <given-names>Michael D.</given-names>
          </name>
        </contrib>
        <aff id="aff1">Centers for Disease Control and Prevention, Atlanta, Georgia USA (S. Roy, K. Rungsrisuriyachai, M.D. Esona, M.E. Wikswo, D.C. Payne, U.D. Parashar, M.D. Bowen); </aff>
        <aff id="aff2">Texas Children&#x2019;s Hospital, Houston, Texas USA (J.A. Boom, L.C. Sahni, C.J. Baker); </aff>
        <aff id="aff3">Baylor College of Medicine, Houston (M.A. Rench, C.J. Baker)</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Michael D. Bowen, 1600 Clifton Rd NE, Mailstop G04, Atlanta, GA 30329-4027, USA; email: <email xlink:href="mkb6@cdc.gov">mkb6@cdc.gov</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>11</month>
        <year>2015</year>
      </pub-date>
      <volume>21</volume>
      <issue>11</issue>
      <fpage>2103</fpage>
      <lpage>2104</lpage>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>rotavirus</kwd>
        <kwd>RotaTeq</kwd>
        <kwd>NSP2 gene</kwd>
        <kwd>nonstructural protein 2 gene</kwd>
        <kwd>reassortant</kwd>
        <kwd>rotavirus</kwd>
        <kwd>viruses</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p><bold>To the Editor:</bold> Group A rotaviruses (RVAs) are a leading cause of acute gastroenteritis-associated deaths among children &lt;5 years of age in developing countries (<xref rid="R1" ref-type="bibr"><italic>1</italic></xref>). The genome of RVA consists of 11 double-stranded RNA segments that code for 11 or 12 viral proteins (VP1&#x2013;VP4, VP6, VP7, nonstructural protein 1 [NSP1]&#x2013;NSP5/6) (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>). In 2008, the Rotavirus Classification Working Group established a system of extended classification that was based on the sequences of all 11 gene segments and used the notations Gx-P[x]-Ix-Rx-Cx-Mx-Ax-Nx-Tx-Ex-Hx for the genes VP7, VP4, VP6, VP1&#x2013;VP3, NSP1&#x2013;NSP5, respectively (<xref rid="R3" ref-type="bibr"><italic>3</italic></xref>). Similar to other RNA viruses, RVAs show high genomic diversity, which is generated primarily through point mutations, reassortment, rearrangement, and recombination events.</p>
    <p>In 2006 and 2008, two live-attenuated vaccines, RotaTeq (Merck, Whitehouse Station, NJ, USA) and Rotarix (GlaxoSmithKline, Rixensart, Belgium), respectively, were introduced in the United States (<xref rid="R4" ref-type="bibr"><italic>4</italic></xref>). RotaTeq is a pentavalent human bovine reassortant vaccine that contains 4 G types (G1, G2, G3, and G4; VP7 gene) plus the P[8] VP4 type on a bovine WC3 (G6P[5]) backbone (<xref rid="R5" ref-type="bibr"><italic>5</italic></xref>). In 2012, Bucardo et al. reported finding a vaccine-derived nonstructural protein 2 (NSP2) gene in 2 wild-type RVA strains with a G1P[8] genogroup 1 backbone (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>). Each of these strains had been found during routine surveillance in Nicaragua, where RotaTeq was introduced in 2006, suggesting reassortment of the vaccine strain with circulating wild-type strains. The authors also examined alignments of the NSP2 gene and found no differences at functional domains between the vaccine-derived NSP2 and the circulating wild-type NSP2 (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>). This finding could explain why a vaccine-derived NSP2 reassortant was viable.</p>
    <p>During the 2010&#x2013;11 surveillance season, the New Vaccine Surveillance Network identified an RVA strain, RVA/human-wt/USA/2011729115/2011/G2P[4] (2011729115), which also contained a vaccine-derived NSP2 gene. This specimen was obtained from a 4-year-old child through routine active surveillance in the emergency department at Texas Children&#x2019;s Hospital (Houston, TX, USA). RVA double-stranded RNA was extracted from a fecal sample from the child by using Trizol reagent (Life Technologies, Grand Island, NY, USA). The sequencing templates were prepared by using sequence-independent whole-genome reverse transcription PCR amplification (<xref rid="R7" ref-type="bibr"><italic>7</italic></xref>) with slight modifications. PCR amplicons were sequenced by the Illumina Miseq 150 paired-end method at the Genomics Laboratory, Hudson Alpha Institute for Biotechnology (Huntsville, AL, USA). Illumina sequence reads were analyzed by using CLC Genomics Workbench 6.0. (<ext-link ext-link-type="uri" xlink:href="http://www.clcbio.com/products/clc-genomics-workbench/">http://www.clcbio.com/products/clc-genomics-workbench/</ext-link>). A combination of de novo assembly followed by mapping to a G2P[4] reference strain was used to obtain the full-length genome of strain 2011729115. The sequences were submitted to GenBank under accession nos. KR701624&#x2013;KR701634. Genotype assignment for each gene was performed by using a combination of BLAST (<ext-link ext-link-type="uri" xlink:href="http://blast.ncbi.nlm.nih.gov/Blast.cgi">http://blast.ncbi.nlm.nih.gov/Blast.cgi</ext-link>) and RotaC 2.0 (<ext-link ext-link-type="uri" xlink:href="http://rotac.regatools.be/">http://rotac.regatools.be/</ext-link>). For each gene, multiple alignments were made by using the MUSCLE algorithm implemented in MEGA 5.1 (<xref rid="R8" ref-type="bibr"><italic>8</italic></xref>). Maximum-likelihood trees were constructed for each gene in PhyML 3.0 (<ext-link ext-link-type="uri" xlink:href="http://www.atgc-montpellier.fr/phyml/">http://www.atgc-montpellier.fr/phyml/</ext-link>) by using the optimal model for each alignment as identified by jModeltest 2 (TrN+I) and approximate-likelihood ratio test (aLRT) statistics computed for branch support (<xref rid="R9" ref-type="bibr"><italic>9</italic></xref>,<xref rid="R10" ref-type="bibr"><italic>10</italic></xref>).</p>
    <p>The full genotype constellation for strain 2011729115 is G2-P[4]-I2-R2-C2-M2-A2-N2-T2-E2-H2, which is a DS-1 like constellation. The G2P[4] strains from the 2010&#x2013;11 season shared 97.6%&#x2013;100% nt identity for the NSP2 gene, except for strain 2011729115, which exhibited only 86.8%&#x2013;87.3% nt identity with the other circulating G2P[4] strains. BLAST analysis of sequences deposited in GenBank indicated that the 2011729115 NSP2 gene was 100% identical to published RotaTeq NSP2 gene sequences and clustered with the 5 RotaTeq NSP2 sequences in phylogenetic analysis (<xref ref-type="fig" rid="F1">Figure</xref>). The NSP2 protein functions as a single-stranded RNA binding protein, nucleic acid helix destabilizer, nucleoside triphosphatase (NTP), nucleoside diphosphate kinase (NDP), and RNA triphosphatase (RTPase) (<xref rid="R2" ref-type="bibr"><italic>2</italic></xref>). No amino acid differences in the RNA binding and NDP/NTP/RTPase domains were found between the NSP2 gene from strain 2011729115 and the G2P[4] strains (data not shown), suggesting that this vaccine-derived NSP2 protein can function like the wild-type version. </p>
    <fig id="F1" fig-type="figure" position="float">
      <label>Figure</label>
      <caption>
        <p>Maximum-likelihood tree for the rotavirus (RVA) nonstructural protein 2 (NSP2) gene showing phylogenetic clustering with wild-type G2P[4] strains identified during the 2010&#x2013;11 season, United States, and RotaTeq (Merck, Whitehouse Station, NJ, USA) vaccine strains. The tree was created by using MEGA 5.1 (<italic>8</italic>). Approximate-likelihood ratio test values &gt;70% are shown next to supported nodes. Boldface indicates strain 2011729115. Scale bar indicates number of nucleotide substitutions per site.</p>
      </caption>
      <graphic xlink:href="15-0850-F"/>
    </fig>
    <p>In conclusion, we identified an NSP2 gene RotaTeq reassortant in an RVA with a DS-1 like genotype. Although the child from whom the NSP2 reassortment specimen was obtained had been vaccinated with a complete regimen of 3 doses of RotaTeq in 2007, no other RotaTeq genes could be detected in the fecal sample. This finding could suggest a reassortment event and infection independent of the vaccination in 2007, although precisely where this reassortment event took place is difficult to ascertain. The existence of a viable NSP2 wild-type reassortant was also proposed by Bucardo et al. (<xref rid="R6" ref-type="bibr"><italic>6</italic></xref>). Whether the RotaTeq NSP2 gene provides any fitness advantage to the virus during infection of vaccinated children also is unclear; during the 2010&#x2013;11 season, other cases of G2P[4]-associated gastroenteritis in vaccinated children, in which the RotaTeq NSP2 gene was lacking, were reported. Our finding of strain RVA/human-wt/USA/2011729115/2011/G2P[4], a wild-type RVA with a vaccine-derived NSP2 gene, in a child with acute gastroenteritis in the United States highlights the need for continued rotavirus surveillance, domestically and internationally, after vaccine introduction.</p>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article</italic>: Roy S, Rungsrisuriyachai K, Esona MD, Boom JA, Sahni LC, Rench MA, et al. G2P[4]-RotaTeq reassortant rotavirus in vaccinated child, United States [letter]. Emerg Infect Dis. 2015 Nov [<italic>date cited</italic>]. <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid2111.150850">http://dx.doi.org/10.3201/eid2111.150850</ext-link></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Tate</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>Burton</surname>
<given-names>AH</given-names></string-name>, <string-name><surname>Boschi-Pinto</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Steele</surname>
<given-names>AD</given-names></string-name>, <string-name><surname>Duque</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Parashar</surname>
<given-names>UD</given-names></string-name>, <etal/>
<article-title>2008 estimate of worldwide rotavirus-associated mortality in children younger than 5 years before the introduction of universal rotavirus vaccination programmes: a systematic review and meta-analysis.</article-title>
<source>Lancet Infect Dis</source>. <year>2012</year>;<volume>12</volume>:<fpage>136</fpage>&#x2013;<lpage>41</lpage> . <pub-id pub-id-type="doi">10.1016/S1473-3099(11)70253-5</pub-id><pub-id pub-id-type="pmid">22030330</pub-id></mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="book"><string-name><surname>Estes</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kapikian</surname>
<given-names>A</given-names></string-name>. Rotaviruses. In: Knipe DM HP, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, editors. Fields virology. 5th ed. Philadelphia: Kluwer/Lippincott, Williams and Wilkins; <year>2007</year>. p. 1917&#x2013;74.</mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Matthijnssens</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Ciarlet</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Rahman</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Attoui</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Banyai</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Estes</surname>
<given-names>MK</given-names></string-name>, <etal/>
<article-title>Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments.</article-title>
<source>Arch Virol</source>. <year>2008</year>;<volume>153</volume>:<fpage>1621</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s00705-008-0155-1</pub-id><pub-id pub-id-type="pmid">18604469</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Cortese</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Parashar</surname>
<given-names>UD</given-names></string-name>. <article-title>Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP).</article-title>
<source>MMWR Recomm Rep</source>. <year>2009</year>;<volume>58</volume>(<issue>RR-2</issue>):<fpage>1</fpage>&#x2013;<lpage>25</lpage>.<pub-id pub-id-type="pmid">19194371</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Matthijnssens</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Joelsson</surname>
<given-names>DB</given-names></string-name>, <string-name><surname>Warakomski</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Zhou</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Mathis</surname>
<given-names>PK</given-names></string-name>, <string-name><surname>van Maanen</surname>
<given-names>MH</given-names></string-name>, <etal/>
<article-title>Molecular and biological characterization of the 5 human-bovine rotavirus (WC3)-based reassortant strains of the pentavalent rotavirus vaccine, RotaTeq.</article-title>
<source>Virology</source>. <year>2010</year>;<volume>403</volume>:<fpage>111</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1016/j.virol.2010.04.004</pub-id><pub-id pub-id-type="pmid">20451234</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="webpage"><string-name><surname>Bucardo</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Rippinger</surname>
<given-names>CM</given-names></string-name>, <string-name><surname>Svensson</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Patton</surname>
<given-names>JT</given-names></string-name>. Vaccine-derived NSP2 segment in rotaviruses from vaccinated children with gastroenteritis in Nicaragua. <ext-link ext-link-type="uri" xlink:href="http://InfectGenetEvol.">Infect Genet Evol.</ext-link>
<year>2012</year>;12:1282&#x2013;94. <ext-link ext-link-type="uri" xlink:href="http://dx.doi:10.1016/j.meegid.2012.03.007">http://dx.doi:10.1016/j.meegid.2012.03.007</ext-link></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Potgieter</surname>
<given-names>AC</given-names></string-name>, <string-name><surname>Page</surname>
<given-names>NA</given-names></string-name>, <string-name><surname>Liebenberg</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Wright</surname>
<given-names>IM</given-names></string-name>, <string-name><surname>Landt</surname>
<given-names>O</given-names></string-name>, <string-name><surname>van Dijk</surname>
<given-names>AA</given-names></string-name>. <article-title>Improved strategies for sequence-independent amplification and sequencing of viral double-stranded RNA genomes.</article-title>
<source>J Gen Virol</source>. <year>2009</year>;<volume>90</volume>:<fpage>1423</fpage>&#x2013;<lpage>32</lpage>. <pub-id pub-id-type="doi">10.1099/vir.0.009381-0</pub-id><pub-id pub-id-type="pmid">19264638</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Tamura</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Peterson</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Peterson</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Stecher</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Nei</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Kumar</surname>
<given-names>S</given-names></string-name>. <article-title>MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods.</article-title>
<source>Mol Biol Evol</source>. <year>2011</year>;<volume>28</volume>:<fpage>2731</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1093/molbev/msr121</pub-id><pub-id pub-id-type="pmid">21546353</pub-id></mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Darriba</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Taboada</surname>
<given-names>GL</given-names></string-name>, <string-name><surname>Doallo</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Posada</surname>
<given-names>D</given-names></string-name>. <article-title>jModelTest 2: more models, new heuristics and parallel computing.</article-title>
<source>Nat Methods</source>. <year>2012</year>;<volume>9</volume>:<fpage>772</fpage>. <pub-id pub-id-type="doi">10.1038/nmeth.2109</pub-id><pub-id pub-id-type="pmid">22847109</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Guindon</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Dufayard</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Lefort</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Anisimova</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Hordijk</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Gascuel</surname>
<given-names>O</given-names></string-name>. <article-title>New algorithms and methods to estimate maximum-likelihood phylogenies: assessing the performance of PhyML 3.0.</article-title>
<source>Syst Biol</source>. <year>2010</year>;<volume>59</volume>:<fpage>307</fpage>&#x2013;<lpage>21</lpage>. <pub-id pub-id-type="doi">10.1093/sysbio/syq010</pub-id><pub-id pub-id-type="pmid">20525638</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
